Squawk Pod: Tariffs, Tech Earnings, FDA Departures, and AI Talent Wars

Global Tariffs and Trade

• 🌍 President Trump has increased tariffs on dozens of countries, with new rates set to take effect within six days, impacting nations like the EU, South Korea, Japan, India, Thailand, and Malaysia.
• 🇨🇦 Canada's tariffs jumped by 10 percentage points to 35% as no deal was reached, while China and Mexico maintained their existing rates.
• 🚪 The President has indicated his door remains open for compelling offers, suggesting potential for further negotiations and deal-making.

Tech Sector Performance and IPO Market

• 🍎 Apple reported its greatest revenue growth in years, with iPhone revenue boosted by customers buying ahead of tariffs, though a $1.1 billion impact is expected in the fourth quarter.
• ☁️ Microsoft's market cap surpassed $4 trillion after strong earnings, while Amazon's stock fell despite solid results due to a disappointing earnings forecast, with AWS growing 17.5%.
• 🚀 Software design company Figma saw a massive surge in its NYSE debut, pricing at $33 and closing over $115, signaling a potentially open IPO window for tech companies.

AI Talent and Investment Landscape

• 💡 Venture capitalist Mitchell Green views the current AI boom as similar to the internet bubble of the late 1990s, expecting significant long-term revolution.
• 💰 He advises retail investors to focus on large hyperscalers like Meta, Amazon, Google, and Microsoft due to their massive capital investments in AI, rather than directly investing in early-stage AI companies.
• 💸 The intense competition for AI talent is leading to insane dilution at private AI companies, with major tech firms offering substantial cash compensation comparable to NBA salaries.

FDA Departures and Regulatory Concerns

• 📉 Dr. Scott Gottlieb highlights a significant degradation at the FDA, with substantial departures of scientific staff impacting early reviews and operations.
• 🔬 The Biologics Center has seen 106 departures this year, and the drug center has lost a third of reviewers for breast and gynecological cancer products, and over half for malignant heme products.
• ⚠️ Gottlieb suggests that political meddling and intrusion in scientific decision-making are eroding morale and impacting the agency's public health mission.

Economic Data and Interest Rates

• 📊 The July jobs report came in weaker than expected, with non-farm payrolls up 73,000 and downward revisions for previous months, potentially influencing Federal Reserve interest rate decisions.
• 📉 President Trump criticized Fed Chair Powell on Truth Social, urging a substantial interest rate reduction, calling him a "disaster."
• 💊 Trump also ordered pharma companies to lower drug prices in the US within 60 days, a move discussed as a starting point for negotiations, potentially impacting global pricing strategies.